 | • レポートコード：MRC2-11QY04542 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は唾液腺感染症のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院、診療所、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別唾液腺感染症の競争状況、市場シェア ・世界の唾液腺感染症市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の唾液腺感染症市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の唾液腺感染症市場：用途別市場規模 2015年-2020年（病院、診療所、家庭用、その他） ・世界の唾液腺感染症市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭用、その他） ・北米の唾液腺感染症市場分析：米国、カナダ ・ヨーロッパの唾液腺感染症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの唾液腺感染症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の唾液腺感染症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの唾液腺感染症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc. (US)、Allergan (Republic of Ireland)、AstraZeneca (UK)、FUJIFILM Holdings Corporation (Japan)、General Electric Company (US)、GlaxoSmithKline plc. (UK)、Johnson & Johnson Services(US)、Merck & Co.(US)、Pfizer Inc.(US)、Siemens Healthcare GmbH (Germany) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.
Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
Market Analysis and Insights: Global Salivary Gland Infection Market
The global Salivary Gland Infection market size is projected to reach US$ 2726.2 million by 2026, from US$ 2618.6 million in 2020, at a CAGR of 3.8%% during 2021-2026.
Global Salivary Gland Infection Scope and Market Size
Salivary Gland Infection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Salivary Gland Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie Inc. (US)
Allergan (Republic of Ireland)
AstraZeneca (UK)
FUJIFILM Holdings Corporation (Japan)
General Electric Company (US)
GlaxoSmithKline plc. (UK)
Johnson & Johnson Services(US)
Merck & Co.(US)
Pfizer Inc.(US)
Siemens Healthcare GmbH (Germany)
Market segment by Type, the product can be split into
Diagnosis
Treatment
Market segment by Application, split into
Hospital
Clinic
Household
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Salivary Gland Infection Revenue
1.4 Market by Type
1.4.1 Global Salivary Gland Infection Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Salivary Gland Infection Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Salivary Gland Infection Market Perspective (2015-2026)
2.2 Global Salivary Gland Infection Growth Trends by Regions
2.2.1 Salivary Gland Infection Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Salivary Gland Infection Historic Market Share by Regions (2015-2020)
2.2.3 Salivary Gland Infection Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Salivary Gland Infection Market Growth Strategy
2.3.6 Primary Interviews with Key Salivary Gland Infection Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Salivary Gland Infection Players by Market Size
3.1.1 Global Top Salivary Gland Infection Players by Revenue (2015-2020)
3.1.2 Global Salivary Gland Infection Revenue Market Share by Players (2015-2020)
3.1.3 Global Salivary Gland Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Salivary Gland Infection Market Concentration Ratio
3.2.1 Global Salivary Gland Infection Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Salivary Gland Infection Revenue in 2019
3.3 Salivary Gland Infection Key Players Head office and Area Served
3.4 Key Players Salivary Gland Infection Product Solution and Service
3.5 Date of Enter into Salivary Gland Infection Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Salivary Gland Infection Historic Market Size by Type (2015-2020)
4.2 Global Salivary Gland Infection Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Salivary Gland Infection Market Size by Application (2015-2020)
5.2 Global Salivary Gland Infection Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Salivary Gland Infection Market Size (2015-2020)
6.2 Salivary Gland Infection Key Players in North America (2019-2020)
6.3 North America Salivary Gland Infection Market Size by Type (2015-2020)
6.4 North America Salivary Gland Infection Market Size by Application (2015-2020)
7 Europe
7.1 Europe Salivary Gland Infection Market Size (2015-2020)
7.2 Salivary Gland Infection Key Players in Europe (2019-2020)
7.3 Europe Salivary Gland Infection Market Size by Type (2015-2020)
7.4 Europe Salivary Gland Infection Market Size by Application (2015-2020)
8 China
8.1 China Salivary Gland Infection Market Size (2015-2020)
8.2 Salivary Gland Infection Key Players in China (2019-2020)
8.3 China Salivary Gland Infection Market Size by Type (2015-2020)
8.4 China Salivary Gland Infection Market Size by Application (2015-2020)
9 Japan
9.1 Japan Salivary Gland Infection Market Size (2015-2020)
9.2 Salivary Gland Infection Key Players in Japan (2019-2020)
9.3 Japan Salivary Gland Infection Market Size by Type (2015-2020)
9.4 Japan Salivary Gland Infection Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Salivary Gland Infection Market Size (2015-2020)
10.2 Salivary Gland Infection Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Salivary Gland Infection Market Size by Type (2015-2020)
10.4 Southeast Asia Salivary Gland Infection Market Size by Application (2015-2020)
11 India
11.1 India Salivary Gland Infection Market Size (2015-2020)
11.2 Salivary Gland Infection Key Players in India (2019-2020)
11.3 India Salivary Gland Infection Market Size by Type (2015-2020)
11.4 India Salivary Gland Infection Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Salivary Gland Infection Market Size (2015-2020)
12.2 Salivary Gland Infection Key Players in Central & South America (2019-2020)
12.3 Central & South America Salivary Gland Infection Market Size by Type (2015-2020)
12.4 Central & South America Salivary Gland Infection Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie Inc. (US)
13.1.1 AbbVie Inc. (US) Company Details
13.1.2 AbbVie Inc. (US) Business Overview
13.1.3 AbbVie Inc. (US) Salivary Gland Infection Introduction
13.1.4 AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2015-2020))
13.1.5 AbbVie Inc. (US) Recent Development
13.2 Allergan (Republic of Ireland)
13.2.1 Allergan (Republic of Ireland) Company Details
13.2.2 Allergan (Republic of Ireland) Business Overview
13.2.3 Allergan (Republic of Ireland) Salivary Gland Infection Introduction
13.2.4 Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2015-2020)
13.2.5 Allergan (Republic of Ireland) Recent Development
13.3 AstraZeneca (UK)
13.3.1 AstraZeneca (UK) Company Details
13.3.2 AstraZeneca (UK) Business Overview
13.3.3 AstraZeneca (UK) Salivary Gland Infection Introduction
13.3.4 AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2015-2020)
13.3.5 AstraZeneca (UK) Recent Development
13.4 FUJIFILM Holdings Corporation (Japan)
13.4.1 FUJIFILM Holdings Corporation (Japan) Company Details
13.4.2 FUJIFILM Holdings Corporation (Japan) Business Overview
13.4.3 FUJIFILM Holdings Corporation (Japan) Salivary Gland Infection Introduction
13.4.4 FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2015-2020)
13.4.5 FUJIFILM Holdings Corporation (Japan) Recent Development
13.5 General Electric Company (US)
13.5.1 General Electric Company (US) Company Details
13.5.2 General Electric Company (US) Business Overview
13.5.3 General Electric Company (US) Salivary Gland Infection Introduction
13.5.4 General Electric Company (US) Revenue in Salivary Gland Infection Business (2015-2020)
13.5.5 General Electric Company (US) Recent Development
13.6 GlaxoSmithKline plc. (UK)
13.6.1 GlaxoSmithKline plc. (UK) Company Details
13.6.2 GlaxoSmithKline plc. (UK) Business Overview
13.6.3 GlaxoSmithKline plc. (UK) Salivary Gland Infection Introduction
13.6.4 GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2015-2020)
13.6.5 GlaxoSmithKline plc. (UK) Recent Development
13.7 Johnson & Johnson Services(US)
13.7.1 Johnson & Johnson Services(US) Company Details
13.7.2 Johnson & Johnson Services(US) Business Overview
13.7.3 Johnson & Johnson Services(US) Salivary Gland Infection Introduction
13.7.4 Johnson & Johnson Services(US) Revenue in Salivary Gland Infection Business (2015-2020)
13.7.5 Johnson & Johnson Services(US) Recent Development
13.8 Merck & Co.(US)
13.8.1 Merck & Co.(US) Company Details
13.8.2 Merck & Co.(US) Business Overview
13.8.3 Merck & Co.(US) Salivary Gland Infection Introduction
13.8.4 Merck & Co.(US) Revenue in Salivary Gland Infection Business (2015-2020)
13.8.5 Merck & Co.(US) Recent Development
13.9 Pfizer Inc.(US)
13.9.1 Pfizer Inc.(US) Company Details
13.9.2 Pfizer Inc.(US) Business Overview
13.9.3 Pfizer Inc.(US) Salivary Gland Infection Introduction
13.9.4 Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2015-2020)
13.9.5 Pfizer Inc.(US) Recent Development
13.10 Siemens Healthcare GmbH (Germany)
13.10.1 Siemens Healthcare GmbH (Germany) Company Details
13.10.2 Siemens Healthcare GmbH (Germany) Business Overview
13.10.3 Siemens Healthcare GmbH (Germany) Salivary Gland Infection Introduction
13.10.4 Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2015-2020)
13.10.5 Siemens Healthcare GmbH (Germany) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Salivary Gland Infection Key Market Segments
Table 2. Key Players Covered: Ranking by Salivary Gland Infection Revenue
Table 3. Ranking of Global Top Salivary Gland Infection Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Salivary Gland Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis
Table 6. Key Players of Treatment
Table 7. Global Salivary Gland Infection Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Salivary Gland Infection Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Salivary Gland Infection Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Salivary Gland Infection Market Share by Regions (2015-2020)
Table 11. Global Salivary Gland Infection Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Salivary Gland Infection Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Salivary Gland Infection Market Growth Strategy
Table 17. Main Points Interviewed from Key Salivary Gland Infection Players
Table 18. Global Salivary Gland Infection Revenue by Players (2015-2020) (Million US$)
Table 19. Global Salivary Gland Infection Market Share by Players (2015-2020)
Table 20. Global Top Salivary Gland Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Salivary Gland Infection as of 2019)
Table 21. Global Salivary Gland Infection by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Salivary Gland Infection Product Solution and Service
Table 24. Date of Enter into Salivary Gland Infection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 27. Global Salivary Gland Infection Market Size Share by Type (2015-2020)
Table 28. Global Salivary Gland Infection Revenue Market Share by Type (2021-2026)
Table 29. Global Salivary Gland Infection Market Size Share by Application (2015-2020)
Table 30. Global Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 31. Global Salivary Gland Infection Market Size Share by Application (2021-2026)
Table 32. North America Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Salivary Gland Infection Market Share (2019-2020)
Table 34. North America Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 35. North America Salivary Gland Infection Market Share by Type (2015-2020)
Table 36. North America Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 37. North America Salivary Gland Infection Market Share by Application (2015-2020)
Table 38. Europe Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Salivary Gland Infection Market Share (2019-2020)
Table 40. Europe Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Salivary Gland Infection Market Share by Type (2015-2020)
Table 42. Europe Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Salivary Gland Infection Market Share by Application (2015-2020)
Table 44. China Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 45. China Key Players Salivary Gland Infection Market Share (2019-2020)
Table 46. China Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 47. China Salivary Gland Infection Market Share by Type (2015-2020)
Table 48. China Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 49. China Salivary Gland Infection Market Share by Application (2015-2020)
Table 50. Japan Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Salivary Gland Infection Market Share (2019-2020)
Table 52. Japan Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Salivary Gland Infection Market Share by Type (2015-2020)
Table 54. Japan Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Salivary Gland Infection Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Salivary Gland Infection Market Share (2019-2020)
Table 58. Southeast Asia Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Salivary Gland Infection Market Share by Type (2015-2020)
Table 60. Southeast Asia Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Salivary Gland Infection Market Share by Application (2015-2020)
Table 62. India Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 63. India Key Players Salivary Gland Infection Market Share (2019-2020)
Table 64. India Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 65. India Salivary Gland Infection Market Share by Type (2015-2020)
Table 66. India Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 67. India Salivary Gland Infection Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Salivary Gland Infection Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Salivary Gland Infection Market Share (2019-2020)
Table 70. Central & South America Salivary Gland Infection Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Salivary Gland Infection Market Share by Type (2015-2020)
Table 72. Central & South America Salivary Gland Infection Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Salivary Gland Infection Market Share by Application (2015-2020)
Table 74. AbbVie Inc. (US) Company Details
Table 75. AbbVie Inc. (US) Business Overview
Table 76. AbbVie Inc. (US) Product
Table 77. AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 78. AbbVie Inc. (US) Recent Development
Table 79. Allergan (Republic of Ireland) Company Details
Table 80. Allergan (Republic of Ireland) Business Overview
Table 81. Allergan (Republic of Ireland) Product
Table 82. Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 83. Allergan (Republic of Ireland) Recent Development
Table 84. AstraZeneca (UK) Company Details
Table 85. AstraZeneca (UK) Business Overview
Table 86. AstraZeneca (UK) Product
Table 87. AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 88. AstraZeneca (UK) Recent Development
Table 89. FUJIFILM Holdings Corporation (Japan) Company Details
Table 90. FUJIFILM Holdings Corporation (Japan) Business Overview
Table 91. FUJIFILM Holdings Corporation (Japan) Product
Table 92. FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 93. FUJIFILM Holdings Corporation (Japan) Recent Development
Table 94. General Electric Company (US) Company Details
Table 95. General Electric Company (US) Business Overview
Table 96. General Electric Company (US) Product
Table 97. General Electric Company (US) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 98. General Electric Company (US) Recent Development
Table 99. GlaxoSmithKline plc. (UK) Company Details
Table 100. GlaxoSmithKline plc. (UK) Business Overview
Table 101. GlaxoSmithKline plc. (UK) Product
Table 102. GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline plc. (UK) Recent Development
Table 104. Johnson & Johnson Services(US) Company Details
Table 105. Johnson & Johnson Services(US) Business Overview
Table 106. Johnson & Johnson Services(US) Product
Table 107. Johnson & Johnson Services(US) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 108. Johnson & Johnson Services(US) Recent Development
Table 109. Merck & Co.(US) Business Overview
Table 110. Merck & Co.(US) Product
Table 111. Merck & Co.(US) Company Details
Table 112. Merck & Co.(US) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 113. Merck & Co.(US) Recent Development
Table 114. Pfizer Inc.(US) Company Details
Table 115. Pfizer Inc.(US) Business Overview
Table 116. Pfizer Inc.(US) Product
Table 117. Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 118. Pfizer Inc.(US) Recent Development
Table 119. Siemens Healthcare GmbH (Germany) Company Details
Table 120. Siemens Healthcare GmbH (Germany) Business Overview
Table 121. Siemens Healthcare GmbH (Germany) Product
Table 122. Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2015-2020) (Million US$)
Table 123. Siemens Healthcare GmbH (Germany) Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Salivary Gland Infection Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Salivary Gland Infection Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Household Case Studies
Figure 8. Other Case Studies
Figure 9. Salivary Gland Infection Report Years Considered
Figure 10. Global Salivary Gland Infection Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Salivary Gland Infection Market Share by Regions: 2020 VS 2026
Figure 12. Global Salivary Gland Infection Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Salivary Gland Infection Market Share by Players in 2019
Figure 15. Global Top Salivary Gland Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Salivary Gland Infection as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Salivary Gland Infection Revenue in 2019
Figure 17. North America Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Salivary Gland Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…- 真菌感染症診断の世界市場（～2026年） ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, …
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…